Xiaodong Wang - May 13, 2025 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Director, Chair, Scientific Advisory Brd
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
May 13, 2025
Transactions value $
-$9,061,832
Form type
4
Date filed
5/15/2025, 05:37 PM
Previous filing
Apr 16, 2025
Next filing
Jun 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wang Xiaodong Director, Chair, Scientific Advisory Brd C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, CAYMAN ISLANDS /s/ Qing Nian, as Attorney-in-Fact 2025-05-15 0001662982

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Options Exercise $271K +41.8K $6.50 41.8K May 13, 2025 Direct F4
transaction BGNE American Depositary Shares Sale -$2.28M -10.2K -24.48% $222.83 31.5K May 13, 2025 Direct F4, F5, F6
transaction BGNE American Depositary Shares Sale -$4.74M -21.2K -67.33% $223.41 10.3K May 13, 2025 Direct F4, F5, F7
transaction BGNE American Depositary Shares Sale -$2.27M -10.1K -98.06% $224.32 200 May 13, 2025 Direct F4, F5, F8
transaction BGNE American Depositary Shares Sale -$45.1K -200 -100% $225.68 0 May 13, 2025 Direct F4, F5
holding BGNE Ordinary Shares 5.08M May 13, 2025 Direct
holding BGNE Ordinary Shares 1.03M May 13, 2025 See Footnote F1
holding BGNE Ordinary Shares 3.95M May 13, 2025 See Footnote F2
holding BGNE Ordinary Shares 50 May 13, 2025 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BGNE Share Option (Right to Buy) Options Exercise $0 -543K -50% $0.00 543K May 13, 2025 Ordinary Shares 543K $0.50 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by the spouse of the Reporting Person.
F4 Each American Depositary Share represents 13 Ordinary Shares.
F5 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.03 to $223.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.03 to $224.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.03 to $224.77, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F9 These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service. The expiration date of the share option is July 19, 2025.